Pharmacotherapy of rheumatoid arthritis;Pharmakotherapie der rheumatoiden arthritis

Zeitschrift fur Rheumatologie

Volumn 61, Issue SUPPL. 2, 2002, Pages

  Gromnica Ihle, E ^a  

^a Rheumaklinik Berlin Buch   (Germany)

Author keywords

DMARD; Remission; Rheumatoid arthritis; Therapeutic strategies

Indexed keywords

CORTICOSTEROID; METHOTREXATE;

ANALGESIA; ARTHROPATHY; ARTICLE; DISEASE COURSE; FITNESS; FOLLOW UP; HUMAN; JOINT DESTRUCTION; REMISSION; RHEUMATOID ARTHRITIS;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; HUMANS; RHEUMATOLOGY;

EID: 17144454174     PISSN: 03401855     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00393-002-1209-5     Document Type: Article

References (27)

1. American College of Rheumatology Task Force on Osteoporosis Guidelines. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis (1996) Arthritis Rheum 39:1791-801
2. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis. 2002 Update (2002) Arthritis Rheum 46:328-346
3. Bathon JM, Martin RW, Fleischmann RM, Tesser JR, Schiff MH, Keystone EC et al (2000) A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med 343:1586-1593
4. Boers M, Verhoeven AC, Markusse HM et al (1997) Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine in early rheumatoid arthritis. Lancet 350:309-318
5. Calgüneri M, Pay S, Caliskaner Z et al (1999) Combination therapy versus monotherapy for the treatment of patients with rheumatoid arthritis. Clin Exp Rheumatol 17:699-704
6. COP QoL. Kooperative zur lebens-qualität bei rheumatischen erkrankungen (2002) Ärzte-Zeitung 21:126
7. Cohen S, Hurd E, Cush J, Schiff M, Weinblatt ME, Moreland LW et al (2002) Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate. Arthritis Rheum 46:614-624
8. nd line therapy: 5 Year followup of a prospective double blind placebo controlled study. J Rheumatol 22:2208-2213
9. Hickling P, Jacoby RK, Kirwan JR, and the Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group (1998) Joint destructions after glucocorticoids are withdrawn in early rheumatoid arthritis. Br J Rheumatol 37:930-936
10. Kirwan JR and the Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group (1995) The effect of glucocorticoids on joint destruction in rheumatoid arthritis. N Engl J Med 333:142-146
11. Kremer JM, Caldwell JR, Cannon GW et al (2000) The combination of leflunomide and methotrexate in patients with active rheumatoid arthritis who are failing on methotrexate treatment alone: A double-blind placebo-controlled study [Abstract]. Arthritis Rheum 44:224
12. Kremer JM, Genovese M, Cannon GW et al (2001) Combination of leflunomide and methotrexate in patients with active rheumatoid arthritis failing MTX Monotherapy: An open-label extension study. Arthrits Rheum 44:549
13. Lipsky PE, van der Heijde DM, St Clair EW et al (2000) Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 343:1594-1602
14. McQueen FM, Stewart N, Crabbe J et al (1998) Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals a high prevalence of erosions at four months after symptom onset. Ann Rheum Dis 57:350-356
15. Möttönen T, Hannonen P, Leirisalo-Repo M et al (1999) Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: A randomized trial. Lancet 353:1568-1573
16. Moreland LW, Schiff MH, Baumgartner SW et al (1999) Etanercept therapy in rheumatoid arthritis: A randomized controlled trial. Ann Intern Med 130:478-486
17. O'Dell JR, Haire CE, Erikson N et al (1996) Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications. N Engl J Med 334:1287-1291
18. O'Dell JR, Leff R, Paulsen G et al (1999) Methotrexate (M)-Hydroxychloroquine(H)-Sulfasalazine(S) versus M-H or M-S for rheumatoid arthritis (RA): Results of a double-blind study [Abstract]. Arthritis Rheum 42 Suppl 9:S117
19. Pinals RS, Masi AT, Larson RA (1981) Preminilary criteria for clinical remission in rheumatoide arthritis. Arthritis Rheum 24:1308-1305
20. Rau R, Wassenberg S, Zeidler H for the LDPT-Study Group (2000) Low dose prednisolone therapy (LDPT) retards radiographically detectable desruction in early rheumatoid arthritis - Preliminary results of a multicenter, randomised, parallel, double blind study. Z Rheumatol 59(suppl 1): 90-96
21. Schattenkirchner M (2001) Kleingruppenarbeit zur erarbeitung zukünftiger maßnahmen und projekte. Z Rheumatol 60:492-493
22. Tsakonas E, Fitzgerald AA, Fitzcharles MA et al (2000) Consequences of delayed therapy with second-line agents in rheumatoid arthritis: A 3 year followup on the hydroxychlorochloroquine in early rheumatoid arthritis (HERA) study. J Rheumatol 27:623-629
23. Tugwell P, Pincus T, Yocum D et al (1995) Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. N Engl J Med 333:137-141
24. Van der Heide A, Jacobs JW, Bijlsma JW et al (1996) The effectiveness of early treatment with "second-line" Antirheumatic drugs: A randomised, controlled trial. Ann Intern Med 124:699-707
25. Wolfe F, Mitchell DM, Sibley JT et al (1994) The mortality of rheumatoid arthritis. Arthritis Rheum 37:481-494
26. Zeidler H, Wollenhaupt J (2001) Kombination von basistherapeutika. Von der individuellen hoffnung zum gezielten einsatz. Z Rheumatol 60:477-480
27. Zink A, Listing J, Niewerth M Zeidler H, for the German Collaborative Arthritis Centres: The nationale database of the German Collaborative Arthritis Centres: II. Treatment of patients with rheumatoid arthritis (2001) Ann Rheum Dis 60:2007-2013